The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study.

PET/MRI Parkinson’s disease amyloid cognitive dysfunction dementia with Lewy bodies

Journal

Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125

Informations de publication

Date de publication:
2021
Historique:
received: 25 05 2021
revised: 08 07 2021
accepted: 13 07 2021
entrez: 30 8 2021
pubmed: 31 8 2021
medline: 31 8 2021
Statut: epublish

Résumé

Dementia in Lewy Body Diseases (Parkinson's disease and dementia with Lewy Bodies) affects progression of disabilities, quality of life and well-being. Understanding its pathogenetic mechanisms is critical to properly implement disease-modifying strategies. It has been hypothesized that synuclein- and amyloid-pathology act synergistically aggravating cognitive decline in elderly patients but their precise contribution to dementia is debated. In this study, we aimed at exploring if presence of amyloid deposits influences clinical, cognitive and neuroanatomical correlates of mental decline in a cohort of 40 Parkinson's disease patients with normal cognition (

Identifiants

pubmed: 34458730
doi: 10.1093/braincomms/fcab180
pii: fcab180
pmc: PMC8390473
doi:

Types de publication

Journal Article

Langues

eng

Pagination

fcab180

Informations de copyright

© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.

Références

J Neurol. 2018 Oct;265(10):2295-2301
pubmed: 30083953
J Neural Transm (Vienna). 2020 Mar;127(3):323-330
pubmed: 31898759
NPJ Parkinsons Dis. 2016 Sep 01;2:16018
pubmed: 28725699
Neuroimage. 2002 Oct;17(2):825-41
pubmed: 12377157
Age Ageing. 1997 Sep;26(5):353-7
pubmed: 9351479
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
J Alzheimers Dis. 2018;63(1):69-73
pubmed: 29504544
Front Neurol Neurosci. 2009;24:114-125
pubmed: 19182469
J Alzheimers Dis. 2013;36(4):613-31
pubmed: 23648516
J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):967-72
pubmed: 1431963
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Brain. 2007 Jul;130(Pt 7):1787-98
pubmed: 17535834
Curr Neurol Neurosci Rep. 2017 Apr;17(4):34
pubmed: 28324303
Neurology. 2021 Apr 6;96(14):e1855-e1864
pubmed: 33593865
Neurology. 2005 Jun 28;64(12):2069-73
pubmed: 15985574
Parkinsonism Relat Disord. 2019 Aug;65:73-78
pubmed: 31109728
Neuropathol Appl Neurobiol. 2016 Aug;42(5):451-62
pubmed: 26810462
Neurology. 2007 Mar 13;68(11):812-9
pubmed: 17353469
Neurology. 2013 Apr 9;80(15):1378-84
pubmed: 23516317
Arch Neurol. 1999 Jan;56(1):33-9
pubmed: 9923759
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
J Neural Transm (Vienna). 2011 May;118(5):713-9
pubmed: 21479514
J Alzheimers Dis Parkinsonism. 2018;8(4):
pubmed: 30473927
Parkinsonism Relat Disord. 2014 Apr;20(4):394-9
pubmed: 24495708
J Neurol Sci. 2010 Feb 15;289(1-2):18-22
pubmed: 19733364
J Neurochem. 2019 Sep;150(5):467-474
pubmed: 30892688
J Alzheimers Dis. 2018;66(1):229-237
pubmed: 30282359
Neurology. 2012 Sep 11;79(11):1161-7
pubmed: 22933741
Nat Rev Neurol. 2020 Apr;16(4):199-212
pubmed: 32203399
Parkinsonism Relat Disord. 2007;13 Suppl 3:S221-4
pubmed: 18267239
Nat Rev Neurosci. 2013 Sep;14(9):626-36
pubmed: 23900411
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Arq Neuropsiquiatr. 2015 May;73(5):390-5
pubmed: 26017203
Ann Neurol. 2019 Feb;85(2):259-271
pubmed: 30549331
J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1258-64
pubmed: 23781007
Nat Rev Neurol. 2010 Feb;6(2):67-77
pubmed: 20139996
Neuroimage. 2002 Jan;15(1):273-89
pubmed: 11771995
J Intern Med. 2015 Sep;278(3):277-90
pubmed: 25752192
Ann Neurol. 2020 May;87(5):739-750
pubmed: 32078179
J Neural Transm (Vienna). 2018 Apr;125(4):615-650
pubmed: 29222591
J Neuropathol Exp Neurol. 2016 Oct;75(10):936-945
pubmed: 27516115
Neurology. 1990 Oct;40(10):1529-34
pubmed: 2215943
Eur Neurol. 1997;37(2):95-9
pubmed: 9058064
Med Image Anal. 2001 Jun;5(2):143-56
pubmed: 11516708
Expert Opin Investig Drugs. 2020 Jul;29(7):685-695
pubmed: 32419521
Brain. 2019 Sep 1;142(9):2860-2872
pubmed: 31280293
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2060-2072
pubmed: 28674847
Acta Neuropathol. 2011 May;121(5):571-87
pubmed: 21516511
Neurobiol Dis. 2018 Jan;109(Pt B):209-218
pubmed: 28751258
Mov Disord. 2015 Jun;30(7):928-35
pubmed: 25879534
J Am Geriatr Soc. 1983 Dec;31(12):721-7
pubmed: 6418786
Lancet Neurol. 2014 Oct;13(10):997-1005
pubmed: 25201514
Neurology. 2013 Jan 1;80(1):85-91
pubmed: 23243071
Mov Disord. 2014 Mar;29(3):351-9
pubmed: 24395708
Neuropathol Appl Neurobiol. 2016 Aug;42(5):436-50
pubmed: 26527105
Neurol Sci. 2013 May;34(5):683-7
pubmed: 22678179
J Alzheimers Dis. 2019;70(2):597-609
pubmed: 31256138
JAMA Netw Open. 2019 Dec 2;2(12):e1916439
pubmed: 31790563
Neurology. 2021 Feb 9;96(6):e904-e915
pubmed: 33219138
Neurology. 2006 Jun 27;66(12):1837-44
pubmed: 16801647
Lancet Neurol. 2017 Jan;16(1):55-65
pubmed: 27979356
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
J Nucl Med. 2016 Jun;57(6):900-6
pubmed: 26823561
J Alzheimers Dis. 2014;42 Suppl 4:S393-400
pubmed: 25261452
Parkinsonism Relat Disord. 2016 Oct;31:72-78
pubmed: 27475955
J Neuropathol Exp Neurol. 2017 Mar 1;76(3):216-224
pubmed: 28395086
Front Neurol. 2019 Apr 24;10:391
pubmed: 31105633
Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837
pubmed: 17542011
Mov Disord Clin Pract. 2016 Jul-Aug;3(4):367-375
pubmed: 27500181
Mol Psychiatry. 2014 Sep;19(9):1044-51
pubmed: 24614494
Front Neurol. 2017 Mar 13;8:89
pubmed: 28348546
Ann Neurol. 2012 Oct;72(4):587-98
pubmed: 23037886
Metabolites. 2020 Sep 23;10(10):
pubmed: 32977481
J Nucl Med. 2016 Aug;57(8):1316-22
pubmed: 27481605
J Neural Transm (Vienna). 2016 Dec;123(12):1435-1442
pubmed: 27334897
Acta Radiol. 2012 Apr 1;53(3):318-23
pubmed: 22371624
Mov Disord. 2008 Apr 30;23(6):837-44
pubmed: 18307261
Intern Med. 2013;52(5):539-45
pubmed: 23448761
J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1234-1243
pubmed: 31444276
Acta Neuropathol. 2006 Sep;112(3):253-60
pubmed: 16804711
Mov Disord. 2014 Feb;29(2):195-202
pubmed: 24123307
J Neural Transm (Vienna). 2020 Mar;127(3):311-322
pubmed: 31912280
Mov Disord. 2012 Mar;27(3):349-56
pubmed: 22275317
Arch Neurol. 2012 Oct;69(10):1326-31
pubmed: 22825369
J Neurol. 2019 Nov;266(11):2605-2619
pubmed: 30377818
Mov Disord. 2018 Feb;33(2):282-288
pubmed: 29205509
Neurology. 2006 Dec 12;67(11):1931-4
pubmed: 17159096
Mov Disord. 2014 Nov;29(13):1615-22
pubmed: 24821648
JAMA. 2015 May 19;313(19):1924-38
pubmed: 25988462
Artif Intell Med. 2020 Mar;103:101807
pubmed: 32143804

Auteurs

Roberta Biundo (R)

Department of General Psychology, University of Padua, Padua, Italy.
Study Center for Neurodegeneration (CESNE), University of Padua, Padua, Italy.

Luca Weis (L)

Parkinson and Movement Disorders Unit, Department of Neuroscience, University of Padua, Padua, Italy.

Eleonora Fiorenzato (E)

Department of General Psychology, University of Padua, Padua, Italy.

Francesca Pistonesi (F)

Parkinson and Movement Disorders Unit, Department of Neuroscience, University of Padua, Padua, Italy.

Annachiara Cagnin (A)

Department of Neuroscience, University of Padua, Padua, Italy.
Padova Neuroscience Center, University of Padua, Padua, Italy.

Alessandra Bertoldo (A)

Department of Information Engineering, University of Padua, Padua, Italy.

Mariagiulia Anglani (M)

Neuroradiology Unit, Padua University Hospital, Padua, Italy.

Diego Cecchin (D)

Padova Neuroscience Center, University of Padua, Padua, Italy.
Nuclear Medicine Unit, Department of Medicine-DIMED, Padua University Hospital, Padua, Italy.

Angelo Antonini (A)

Parkinson and Movement Disorders Unit, Department of Neuroscience, University of Padua, Padua, Italy.
Padova Neuroscience Center, University of Padua, Padua, Italy.

Classifications MeSH